Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings MissesNews
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.36) by 3.68 percent. This is a 29.5 percent increase over losses of $(2.00) per share
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.36) by 3.68 percent. This is a 29.5 percent increase over losses of $(2.00) per share from the same period last year. The company reported quarterly sales of $33.318 million which missed the analyst consensus estimate of $37.617 million by 11.43 percent. This is a 24.01 percent decrease over sales of $43.847 million the same period last year.